Sionna Therapeutics (SION) Competitors $11.07 +1.07 (+10.70%) As of 04/17/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesSEC FilingsTrendsBuy This Stock SION vs. BLTE, DNLI, SDGR, NAMS, GMTX, JANX, BEAM, BHC, KYMR, and GLPGShould you be buying Sionna Therapeutics stock or one of its competitors? The main competitors of Sionna Therapeutics include Belite Bio (BLTE), Denali Therapeutics (DNLI), Schrödinger (SDGR), NewAmsterdam Pharma (NAMS), Gemini Therapeutics (GMTX), Janux Therapeutics (JANX), Beam Therapeutics (BEAM), Bausch Health Companies (BHC), Kymera Therapeutics (KYMR), and Galapagos (GLPG). These companies are all part of the "pharmaceutical products" industry. Sionna Therapeutics vs. Belite Bio Denali Therapeutics Schrödinger NewAmsterdam Pharma Gemini Therapeutics Janux Therapeutics Beam Therapeutics Bausch Health Companies Kymera Therapeutics Galapagos Sionna Therapeutics (NASDAQ:SION) and Belite Bio (NASDAQ:BLTE) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their media sentiment, profitability, institutional ownership, earnings, risk, community ranking, valuation, analyst recommendations and dividends. Does the MarketBeat Community believe in SION or BLTE? Belite Bio received 31 more outperform votes than Sionna Therapeutics when rated by MarketBeat users. However, 100.00% of users gave Sionna Therapeutics an outperform vote while only 97.14% of users gave Belite Bio an outperform vote. CompanyUnderperformOutperformSionna TherapeuticsOutperform Votes3100.00% Underperform VotesNo VotesBelite BioOutperform Votes3497.14% Underperform Votes12.86% Do insiders & institutionals have more ownership in SION or BLTE? 0.5% of Belite Bio shares are owned by institutional investors. 13.3% of Belite Bio shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Do analysts rate SION or BLTE? Sionna Therapeutics presently has a consensus target price of $38.50, suggesting a potential upside of 247.79%. Belite Bio has a consensus target price of $96.67, suggesting a potential upside of 71.39%. Given Sionna Therapeutics' higher possible upside, analysts plainly believe Sionna Therapeutics is more favorable than Belite Bio.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sionna Therapeutics 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00Belite Bio 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is SION or BLTE more profitable? Sionna Therapeutics' return on equity of 0.00% beat Belite Bio's return on equity.Company Net Margins Return on Equity Return on Assets Sionna TherapeuticsN/A N/A N/A Belite Bio N/A -31.94%-30.73% Which has preferable valuation & earnings, SION or BLTE? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSionna TherapeuticsN/AN/AN/AN/AN/ABelite BioN/AN/A-$31.63M-$1.18-47.80 Does the media prefer SION or BLTE? In the previous week, Belite Bio had 6 more articles in the media than Sionna Therapeutics. MarketBeat recorded 6 mentions for Belite Bio and 0 mentions for Sionna Therapeutics. Belite Bio's average media sentiment score of 0.20 beat Sionna Therapeutics' score of 0.00 indicating that Belite Bio is being referred to more favorably in the news media. Company Overall Sentiment Sionna Therapeutics Neutral Belite Bio Neutral SummaryBelite Bio beats Sionna Therapeutics on 6 of the 10 factors compared between the two stocks. Get Sionna Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SION and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SION vs. The Competition Export to ExcelMetricSionna Therapeutics IndustryMedical SectorNASDAQ ExchangeMarket Cap$488.45M$2.59B$5.31B$7.35BDividend YieldN/A13.19%5.47%4.31%P/E RatioN/A11.2021.9417.82Price / SalesN/A2,058,869.58380.9497.68Price / CashN/A16.6538.3134.64Price / BookN/A3.106.453.98Net IncomeN/A$37.31M$3.22B$247.81M7 Day Performance40.66%0.43%5.85%3.19%1 Month Performance-20.24%-4.45%-9.58%-7.70%1 Year PerformanceN/A1.67%11.85%1.49% Sionna Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SIONSionna TherapeuticsN/A$11.07+10.7%$38.50+247.8%N/A$488.45MN/A0.0035Gap DownBLTEBelite Bio2.6331 of 5 stars$58.27+1.7%$96.67+65.9%+68.7%$1.86BN/A-52.5010Short Interest ↓Analyst RevisionNews CoverageDNLIDenali Therapeutics4.0137 of 5 stars$12.67+1.0%$37.57+196.5%-20.4%$1.85B$330.53M-4.62430SDGRSchrödinger2.3748 of 5 stars$25.05-0.6%$33.00+31.7%+6.0%$1.84B$207.54M-10.79790Analyst ForecastInsider TradeNews CoverageNAMSNewAmsterdam Pharma2.4544 of 5 stars$16.45+2.6%$43.33+163.5%-18.0%$1.80B$45.56M-6.314Short Interest ↑GMTXGemini TherapeuticsN/A$41.31+2.6%N/A+40.5%$1.79BN/A-41.3130High Trading VolumeJANXJanux Therapeutics2.6122 of 5 stars$29.28+2.0%$95.25+225.4%-39.0%$1.73B$10.59M-25.0830Positive NewsBEAMBeam Therapeutics2.8279 of 5 stars$17.08+2.8%$49.45+189.6%-28.9%$1.71B$63.52M-9.76510Short Interest ↑BHCBausch Health Companies4.0036 of 5 stars$4.60+2.1%$7.17+56.0%-41.0%$1.69B$9.63B-38.2119,900Short Interest ↑News CoverageGap UpKYMRKymera Therapeutics1.5189 of 5 stars$25.22+0.8%$56.36+123.4%-23.6%$1.65B$47.07M-10.86170Positive NewsGLPGGalapagos0.6745 of 5 stars$24.83+1.3%$25.33+2.0%-15.2%$1.64B$275.65M0.001,310Upcoming EarningsNews Coverage Related Companies and Tools Related Companies BLTE Alternatives DNLI Alternatives SDGR Alternatives NAMS Alternatives GMTX Alternatives JANX Alternatives BEAM Alternatives BHC Alternatives KYMR Alternatives GLPG Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SION) was last updated on 4/20/2025 by MarketBeat.com Staff From Our PartnersThe real reason gold is soaring (and likely to continue)Trump’s Policies Are Fueling a Gold Boom—Here’s Your Chance to Profit Donald Trump’s bold policies are driv...Golden Portfolio | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredThe first casualty of the 2025 trade warThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sionna Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sionna Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SION Stock Free SION Stock Alerts